Contents
Issue 157 • August 2025
In association with
In Depth
Can rare disease research in the US thrive under the new administration?
Protocol flexibility and navigating the US geopolitical landscape in oncology clinical trials
EU’s Pharma Package falls short of Europe’s goal of global competitiveness
How will RFK Jr’s American dream for vaccines play out?
From discovery to delivery: making therapies reach patients faster
ADCs on the rise: US manufacturing funding grows